Assignee
INSTIL BIO UK LTD
GB·9 granted patents·13 pending applications·6 citations·filing 2016–2023
Top patents by PatentIndex Score
22 records- 0187US12187778B2Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Jan 7, 2025·1 cites·13 claims
- 0287US11945876B2Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Apr 2, 2024·2 cites·14 claims
- 0386US12173271B2Aseptic tissue processing method, kit and deviceINSTIL BIO UK LTD·Filed 2023·Granted Dec 24, 2024·0 cites·8 claims
- 0486US11697677B2Chimeric molecules providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Jul 11, 2023·2 cites·25 claims
- 0582US11618877B2Aseptic tissue processing method, kit and deviceINSTIL BIO UK LTD·Filed 2022·Granted Apr 4, 2023·0 cites·17 claims
- 0682US11618878B2Aseptic tissue processing method, kit and deviceINSTIL BIO UK LTD·Filed 2022·Granted Apr 4, 2023·0 cites·15 claims
- 0773US2024018476A1Devices and methods for isolating tumor infiltrating lymphocytes and uses thereofINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 0873US2024067929A1Devices and methods for isolating tumor infiltrating lymphocytes and uses thereofINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 0972US11767510B2Devices and methods for isolating tumor infiltrating lymphocytes and uses thereofINSTIL BIO UK LTD·Filed 2022·Granted Sep 26, 2023·0 cites·14 claims
- 1071US12116564B2Cells expressing recombinant growth factor receptorsINSTIL BIO UK LTD·Filed 2022·Granted Oct 15, 2024·0 cites·12 claims
- 1171US11530386B2Cells expressing recombinant growth factor receptorsINSTIL BIO UK LTD·Filed 2016·Granted Dec 20, 2022·1 cites·22 claims
- 1270US2022356448A1Devices and methods for isolating tumor infiltrating lymphocytes and uses thereofINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 1363US2022348631A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 1463US2023331808A1Chimeric molecules providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 1563US2023055694A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 1662US2024058447A1Use of fusion constructs for il-2 independent t cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 1756US2023227576A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 1854US2022160760A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2021·Application pending·0 cites
- 1951US2022378826A1Tumour infiltrating lymphocyte therapy and uses thereofINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 2047US2024269280A1Processing of tumor infiltrating lymphocytesINSTIL BIO UK LTD·Filed 2021·Application pending·0 cites
- 2144US2021205365A1Chimeric Growth Factor ReceptorsINSTIL BIO UK LTD·Filed 2020·Application pending·0 cites
- 2242US2021000872A1Biomarker predictive of tumour infiltrating lymphocyte therapy and uses thereofINSTIL BIO UK LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INSTIL BIO UK LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →